UCB(UCB)
UCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.11B | $1.14B | $1.07B |
| Low | $1.08B | $1.10B | $1.05B |
| High | $1.13B | $1.17B | $1.08B |
| EBITDA Avg | $370M | $383M | $357M |
| Low | $361M | $370M | $350M |
| High | $380M | $393M | $363M |
| EBIT Avg | $341M | $353M | $329M |
| Low | $332M | $341M | $322M |
| High | $350M | $362M | $334M |
| Net Income Avg | $351M | $394M | $429M |
| Low | $350M | $383M | $419M |
| High | $357M | $405M | $439M |
| EPS Avg | $2.91 | $3.22 | $3.53 |
| Low | $2.87 | $3.15 | $3.44 |
| High | $2.93 | $3.32 | $3.61 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 5 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $277M | $276M | $275M | $283M | $291M | $295M | $280M | $280M |
| Low | $275M | $266M | $270M | $278M | $286M | $289M | $274M | $275M |
| High | $279M | $283M | $279M | $287M | $295M | $299M | $284M | $284M |
| EBITDA Avg | $93M | $92M | $92M | $95M | $97M | $99M | $94M | $94M |
| Low | $92M | $89M | $90M | $93M | $96M | $97M | $92M | $92M |
| High | $93M | $95M | $93M | $96M | $99M | $100M | $95M | $95M |
| EBIT Avg | $85M | $85M | $85M | $87M | $90M | $91M | $86M | $86M |
| Low | $85M | $82M | $83M | $86M | $88M | $89M | $85M | $85M |
| High | $86M | $87M | $86M | $89M | $91M | $92M | $88M | $88M |
| Net Income Avg | $89M | $89M | $90M | $95M | $100M | $103M | $100M | $105M |
| Low | $87M | $86M | $88M | $93M | $98M | $100M | $97M | $102M |
| High | $90M | $94M | $92M | $97M | $102M | $105M | $102M | $107M |
| EPS Avg | $0.74 | $0.74 | $0.75 | $0.79 | $0.83 | $0.85 | $0.83 | $0.87 |
| Low | $0.72 | $0.71 | $0.73 | $0.77 | $0.81 | $0.83 | $0.81 | $0.85 |
| High | $0.75 | $0.78 | $0.76 | $0.80 | $0.85 | $0.87 | $0.85 | $0.89 |
| Analysts (Rev / EPS) | 3 / 5 | 4 / 5 | 2 / 3 | 2 / 3 | 2 / 3 | 2 / 3 | 1 / 4 | 1 / 4 |